The Impact of Activity-Based Protein Profiling in Malaria Drug Discovery

被引:10
作者
Carvalho, Luis A. R. [1 ]
Bernardes, Goncalo J. L. [1 ,2 ]
机构
[1] Univ Cambridge, Yusuf Hamied Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England
[2] Inst Med Mol Joao Lobo Antunes, Ave Prof Egas Moniz, P-1649028 Lisbon, Portugal
基金
欧盟地平线“2020”;
关键词
Drug Discovery; Fluorescent probes; Malaria; Mass spectrometry; Proteomics; ACTIVITY-BASED PROBES; SMALL-MOLECULE INHIBITORS; PLASMODIUM-FALCIPARUM; CYSTEINE PROTEASE; FUNCTIONAL PROTEOMICS; SERINE HYDROLASES; ARTEMISININ; SITE; IDENTIFICATION; REVEALS;
D O I
10.1002/cmdc.202200174
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Activity-based protein profiling (ABPP) is an approach used at the interface of chemical biology and proteomics that uses small molecular probes to provide dynamic fingerprints of enzymatic activity in complex proteomes. Malaria is a disease caused by Plasmodium parasites with a significant death burden and for which new therapies are actively being sought. Here, we compile the main achievements from ABPP studies in malaria and highlight the probes used and the different downstream platforms for data analysis. ABPP has excelled at studying Plasmodium cysteine proteases and serine hydrolase families, the targeting of the proteasome and metabolic pathways, and in the deconvolution of targets and mechanisms of known antimalarials. Despite the major impact in the field, many antimalarials and enzymatic families in Plasmodium remain to be studied, which suggests ABPP will be an evergreen technique in the field.
引用
收藏
页数:17
相关论文
共 67 条
  • [1] Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum
    Arastu-Kapur, Shirin
    Ponder, Elizabeth L.
    Fonovic, Ursa Pecar
    Yeoh, Sharon
    Yuan, Fang
    Fonovic, Marko
    Grainger, Munira
    Phillips, Carolyn I.
    Powers, James C.
    Bogyo, Matthew
    [J]. NATURE CHEMICAL BIOLOGY, 2008, 4 (03) : 203 - 213
  • [2] Identification by functional proteomics of a deubiquitinating/deNeddylating enzyme in Plasmodium falciparum
    Artavanis-Tsakonas, Katerina
    Misaghi, Shahram
    Comeaux, Christy A.
    Catic, Andre
    Spooner, Eric
    Duraisingh, Manoj T.
    Ploegh, Hidde L.
    [J]. MOLECULAR MICROBIOLOGY, 2006, 61 (05) : 1187 - 1195
  • [3] REACTION OF ANTIMALARIAL ENDOPEROXIDES WITH SPECIFIC PARASITE PROTEINS
    ASAWAMAHASAKDA, W
    ITTARAT, I
    PU, YM
    ZIFFER, H
    MESHNICK, SR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (08) : 1854 - 1858
  • [4] PlasmoDB: a functional genomic database for malaria parasites
    Aurrecoechea, Cristina
    Brestelli, John
    Brunk, Brian P.
    Dommer, Jennifer
    Fischer, Steve
    Gajria, Bindu
    Gao, Xin
    Gingle, Alan
    Grant, Greg
    Harb, Omar S.
    Heiges, Mark
    Innamorato, Frank
    Iodice, John
    Kissinger, Jessica C.
    Kraemer, Eileen
    Li, Wei
    Miller, John A.
    Nayak, Vishal
    Pennington, Cary
    Pinney, Deborah F.
    Roos, David S.
    Ross, Chris
    Stoeckert, Christian J., Jr.
    Treatman, Charles
    Wang, Haiming
    [J]. NUCLEIC ACIDS RESEARCH, 2009, 37 : D539 - D543
  • [5] The pharmacological landscape and therapeutic potential of serine hydrolases
    Bachovchin, Daniel A.
    Cravatt, Benjamin F.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (01) : 52 - 68
  • [6] Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening
    Bachovchin, Daniel A.
    Ji, Tianyang
    Li, Weiwei
    Simon, Gabriel M.
    Blankman, Jacqueline L.
    Adibekian, Alexander
    Hoover, Heather
    Niessen, Sherry
    Cravatt, Benjamin F.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (49) : 20941 - 20946
  • [7] Baggelaar MP, 2017, METHODS MOL BIOL, V1491, P161, DOI 10.1007/978-1-4939-6439-0_12
  • [8] Rationale Design of Biotinylated Antimalarial Endoperoxide Carbon Centered Radical Prodrugs for Applications in Proteomics
    Barton, Victoria
    Ward, Steven A.
    Chadwick, James
    Hill, Alasdair
    ONeill, Paul M.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (11) : 4555 - 4559
  • [9] Cysteine proteases as disease markers
    Berdowska, I
    [J]. CLINICA CHIMICA ACTA, 2004, 342 (1-2) : 41 - 69
  • [10] Dynamic imaging of protease activity with fluorescently quenched activity-based probes
    Blum, G
    Mullins, SR
    Keren, K
    Fonovic, M
    Jedeszko, C
    Rice, MJ
    Sloane, BF
    Bogyo, M
    [J]. NATURE CHEMICAL BIOLOGY, 2005, 1 (04) : 203 - 209